Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk
Journal Title: Нирки - Year 2018, Vol 7, Issue 2
Abstract
Reducing the risk of cardiovascular events is one of the most topical issues of modern medicine. Patients with chronic kidney disease stage 3 or lower, according to international guidelines, refer to the group with high and very high cardiovascular risk. At the moment, all the existing recommendations share the view that the first-line drugs for lowering blood pressure among this group of patients are renin-angiotensin-aldosterone system blockers. When renal and cardiovascular pathologies are combined, in addition to traditional risk factors, there are non-traditional kidney risk factors too (anaemia, hyperhydration, hypercoagulation, etc.). Combined antihypertensive therapy is preferable in order to achieve more significant reduction in global cardiovascular risk and closer control of blood pressure.
Authors and Affiliations
D. D. Ivanov, O. V. Kuryata, I. P. Garmysh
Keywords
Related Articles
- EP ID EP280815
- DOI 10.22141/2307-1257.7.2.2018.127393
- Views 97
- Downloads 0
Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...
Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients?
The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study reveal...
Loop Diuterics: What Effect Do WE Expect from Different Doses and Various Forms of Release?
.
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the share initiative
.
Violation of renal and peripheral hemodynamics in the development of cardiovascular disorders in children with chronic pyelonephritis
Background. Prompt detection of changes in the cardiovascular system in children with chronic pyelonephritis is important for slowing down the development of arterial hypertension and the progression of chronic kidney di...